慢性自发性荨麻疹-话题@MedSci

#慢性自发性荨麻疹#

13篇内容 | 1022人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2172031, encodeId=9b8121e2031b9, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a> <a href='/topic/show?id=9cfb1088ee6' target=_blank style='color:#2F92EE;'>#Ligelizumab#</a> <a href='/topic/show?id=563b108045c3' target=_blank style='color:#2F92EE;'>#单克隆抗免疫球蛋白#</a>, objectTitle=难治性荨麻疹新“克星”！《柳叶刀》：治疗4周起效，12周症状显著改善！, objectType=article, longId=802939, objectId=dabe802939ec, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=dabe802939ec, replyNumber=0, likeNumber=27, createdTime=2023-11-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=dabe802939ec, moduleTitle=难治性荨麻疹新“克星”！《柳叶刀》：治疗4周起效，12周症状显著改善！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dabe802939ec)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1378800, encodeId=16a313e880086, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=赛诺菲/再生元的Dupixent在第二次慢性自发性荨麻疹研究中表现欠佳, objectType=article, longId=299150, objectId=53072991502c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53072991502c, replyNumber=0, likeNumber=62, createdTime=2022-02-20, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53072991502c, moduleTitle=赛诺菲/再生元的Dupixent在第二次慢性自发性荨麻疹研究中表现欠佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53072991502c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378799, encodeId=968713e87995c, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=Front Immunol ：新冠肺炎对慢性自发性荨麻疹患者的影响竟然有性别差异？, objectType=article, longId=221193, objectId=ae4622119352, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae4622119352, replyNumber=0, likeNumber=42, createdTime=2021-11-29, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae4622119352, moduleTitle=Front Immunol ：新冠肺炎对慢性自发性荨麻疹患者的影响竟然有性别差异？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae4622119352)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378798, encodeId=294713e879823, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=Nat Med：非布替尼治疗H1抗组胺药难治性慢性自发性荨麻疹, objectType=article, longId=220068, objectId=3f4e22006800, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f4e22006800, replyNumber=0, likeNumber=33, createdTime=2021-11-11, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f4e22006800, moduleTitle=Nat Med：非布替尼治疗H1抗组胺药难治性慢性自发性荨麻疹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f4e22006800)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378801, encodeId=9cf513e880172, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=奥马珠单抗治疗慢性自发性荨麻疹在华获批，开启生物制剂治疗新时代, objectType=article, longId=267099, objectId=00db26e09956, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00db26e09956, replyNumber=0, likeNumber=53, createdTime=2021-11-10, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00db26e09956, moduleTitle=奥马珠单抗治疗慢性自发性荨麻疹在华获批，开启生物制剂治疗新时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00db26e09956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378797, encodeId=f82d13e879786, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=赛诺菲、再生元的Dupixent在慢性自发性荨麻疹中取得积极成果, objectType=article, longId=215175, objectId=1f472151e583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f472151e583, replyNumber=0, likeNumber=39, createdTime=2021-08-03, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f472151e583, moduleTitle=赛诺菲、再生元的Dupixent在慢性自发性荨麻疹中取得积极成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f472151e583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378796, encodeId=d7a613e87963b, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=Am J Clin Pathol：幽门螺杆菌治疗对慢性自发性荨麻疹患者结局的影响, objectType=article, longId=214776, objectId=f7b9214e76ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b9214e76ba, replyNumber=0, likeNumber=46, createdTime=2021-07-26, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b9214e76ba, moduleTitle=Am J Clin Pathol：幽门螺杆菌治疗对慢性自发性荨麻疹患者结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7b9214e76ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378795, encodeId=020d13e87953d, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=重大突破！新型疗法让慢性自发性荨麻疹控制不再难！, objectType=article, longId=211569, objectId=dc652115699a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc652115699a, replyNumber=0, likeNumber=39, createdTime=2021-05-22, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc652115699a, moduleTitle=重大突破！新型疗法让慢性自发性荨麻疹控制不再难！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc652115699a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378794, encodeId=96b813e87942a, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=J Allergy Clin Immunol：奥马珠单抗治疗慢性自发性荨麻疹的疗效与嗜碱性粒细胞表型有关, objectType=article, longId=208465, objectId=f3ea20846576, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ea20846576, replyNumber=0, likeNumber=33, createdTime=2021-03-17, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ea20846576, moduleTitle=J Allergy Clin Immunol：奥马珠单抗治疗慢性自发性荨麻疹的疗效与嗜碱性粒细胞表型有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ea20846576)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378793, encodeId=214713e879372, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=慢性自发性荨麻疹(CSU)新药！诺华新一代IgE抗体ligelizumab获美国FDA突破性药物资格!, objectType=article, longId=205804, objectId=2e6320580469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e6320580469, replyNumber=0, likeNumber=38, createdTime=2021-01-18, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e6320580469, moduleTitle=慢性自发性荨麻疹(CSU)新药！诺华新一代IgE抗体ligelizumab获美国FDA突破性药物资格!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e6320580469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378792, encodeId=586613e8792cd, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=J Dermatolog Treat：氨纶治疗慢性自发性荨麻疹和其他皮肤病患者瘙痒症的疗效, objectType=article, longId=196529, objectId=31b619652925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31b619652925, replyNumber=0, likeNumber=35, createdTime=2020-06-27, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31b619652925, moduleTitle=J Dermatolog Treat：氨纶治疗慢性自发性荨麻疹和其他皮肤病患者瘙痒症的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31b619652925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378791, encodeId=a68113e87918c, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=NEJM的：诺华的IgE单抗Ligelizumab在慢性自发性荨麻疹的III期临床中完胜奥马珠单抗, objectType=article, longId=186027, objectId=868418602e8e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=868418602e8e, replyNumber=0, likeNumber=41, createdTime=2020-01-11, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=868418602e8e, moduleTitle=NEJM的：诺华的IgE单抗Ligelizumab在慢性自发性荨麻疹的III期临床中完胜奥马珠单抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=868418602e8e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378790, encodeId=e53413e87903d, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=NEJM：利格珠单抗治疗慢性自发性荨麻疹的疗效分析, objectType=article, longId=180462, objectId=709c180462c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=709c180462c5, replyNumber=0, likeNumber=39, createdTime=2019-10-05, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=709c180462c5, moduleTitle=NEJM：利格珠单抗治疗慢性自发性荨麻疹的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=709c180462c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378789, encodeId=0e6413e8789cc, content=<a href='/topic/show?id=f263536e74f' target=_blank style='color:#2F92EE;'>#慢性自发性荨麻疹#</a>, objectTitle=Allergy：慢性自发性荨麻疹患者CRP与疾病活动性和治疗反应性有关！, objectType=article, longId=119786, objectId=5a00119e86c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a00119e86c7, replyNumber=0, likeNumber=31, createdTime=2017-11-14, rootId=0, userName=jjjiang0199, userId=5319428, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a00119e86c7, moduleTitle=Allergy：慢性自发性荨麻疹患者CRP与疾病活动性和治疗反应性有关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a00119e86c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

慢性自发性荨麻疹

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹# #Ligelizumab# #单克隆抗免疫球蛋白#

难治性荨麻疹新“克星”！《柳叶刀》：治疗4周起效，12周症状显著改善！

2023-11-30发表于上海

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

赛诺菲/再生元的Dupixent在第二次慢性自发性荨麻疹研究中表现欠佳

2022-02-20

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

Front Immunol ：新冠肺炎对慢性自发性荨麻疹患者的影响竟然有性别差异？

2021-11-29

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

Nat Med：非布替尼治疗H1抗组胺药难治性慢性自发性荨麻疹

2021-11-11

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

奥马珠单抗治疗慢性自发性荨麻疹在华获批，开启生物制剂治疗新时代

2021-11-10

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

赛诺菲、再生元的Dupixent在慢性自发性荨麻疹中取得积极成果

2021-08-03

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

Am J Clin Pathol：幽门螺杆菌治疗对慢性自发性荨麻疹患者结局的影响

2021-07-26

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

重大突破！新型疗法让慢性自发性荨麻疹控制不再难！

2021-05-22

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

J Allergy Clin Immunol：奥马珠单抗治疗慢性自发性荨麻疹的疗效与嗜碱性粒细胞表型有关

2021-03-17

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

慢性自发性荨麻疹(CSU)新药！诺华新一代IgE抗体ligelizumab获美国FDA突破性药物资格!

2021-01-18

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

J Dermatolog Treat：氨纶治疗慢性自发性荨麻疹和其他皮肤病患者瘙痒症的疗效

2020-06-27

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

NEJM的：诺华的IgE单抗Ligelizumab在慢性自发性荨麻疹的III期临床中完胜奥马珠单抗

2020-01-11

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

NEJM：利格珠单抗治疗慢性自发性荨麻疹的疗效分析

2019-10-05

jjjiang0199 (审核中...)

前往app查看评论内容

#慢性自发性荨麻疹#

Allergy：慢性自发性荨麻疹患者CRP与疾病活动性和治疗反应性有关！

2017-11-14

科室
- - 订阅+
  - 更多科室
工具
服务